RPG Life Sciences shifts gears, bets on chronic drugs to expand sales, profits
The drugmaker wants the chronic segment to account for 50 percent of revenue. Currently, RPG Life Sciences' business mix is heavily skewed towards acute drugs, with over two-thirds of sales coming from this segment
RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter ended September 30, 2020. Kindly take this information on record. RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter ended September 30, 2020. Kindly take this information on record. RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2020. Kindly take the above on record. RPG LIFE SCIENCES LTD. - 532983 - Unaudited Financial Result For The Quarter And Half Year Ended September 30, 2020
Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and half year ended September 30, 2020 which were approved by the Board of Directors of the Company, at its meeting held on October 30, 2020 along with Limited Review Report issued by the Statutory Auditors of the Company. The meeting commenced at 03:00 p.m. and concluded at 05.00 p.m. Kindly take the above on record. RPG LIFE SCIENCES LTD. - 532983 - Outcome Of Board Meeting Held On October 30, 2020
In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Friday, October 30, 2020, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2020 along with Limited Review Report of the Statutory Auditors thereon. The meeting commenced at 03:00 p.m. and concluded at 05.00 p.m. Kindly take the above on record. RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper notice published to give intimation of the meeting of Board of Directors of the Company scheduled to be held on October 30, 2020, inter alia, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2020. Kindly take this information on record. RPG LIFE SCIENCES LTD. - 532983 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020
RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, October 30, 2020, inter-alia, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2020. Further, pursuant to the Code of Fair Disclosure (including Policy on determination of Legitimate Purpose) and Code of Conduct to Regulate, Monitor and Report Trading by Designated Person(s) of the Company, the Trading Window for dealing in Securities by Designated Persons and their immediate relatives, is closed from October 1, 2020 and will continue to remain closed till 48 hours after the results are made public on October 30, 2020. Kindly take this information on record. RPG Life Sciences Ltd - 532983 - Shareholding for the Period Ended September 30, 2020
RPG Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here RPG LIFE SCIENCES LTD. - 532983 - Compliance Certificate Under Regulation 40(9)
We enclose herewith certificate issued by Practicing Company Secretary, pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended September 30, 2020. Kindly take the same on record.